OGN — Organon & Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual balance sheet for Organon & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-Q	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	319	12	737	706	693
Net Total Accounts Receivable
Net Total Receivables	1,661	1,353	1,497	1,585	1,857
Total Inventory
Total Other Current Assets
Total Current Assets	3,955	3,567	3,760	3,931	4,508
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	762	1,015	1,203	1,233	1,356
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	10,548	10,109	10,681	10,955	12,058
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,341	2,673	2,597	2,512	2,918
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	3,513	4,623	12,189	11,847	12,128
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	7,035	5,486	-1,508	-892	-70
Total Liabilities & Shareholders' Equity	10,548	10,109	10,681	10,955	12,058
Total Common Shares Outstanding